Zobrazeno 1 - 10
of 147
pro vyhledávání: ''
Autor:
Brian D. Badgwell, Catherine E Devine, Yang Lu, Jane E. Rogers, Ahmed Abdelhakeem, Allison Trail, Naruhiko Ikoma, Tara Sagebiel, Xuemei Wang, Jeannelyn S. Estrella, Madhavi Patnana, Jaffer A. Ajani, Mariela A. Blum Murphy
Publikováno v:
Oncology. 99:659-664
Background: The value of baseline fluorodeoxyglucose-positron emission tomography-computed tomography (PET-CT) remains uncertain once gastroesophageal cancer is metastatic. We hypothesized that assessment of detailed PET-CT parameters (maximum standa
Autor:
Savtaj S. Brar, Carol Jane Swallow, Charles Henry Lim, Hao-Wen Sim, Jennifer J. Knox, Bryan A. Chan, Akina Natori, James Brierley, Osvaldo Espin-Garcia, Rebecca Wong, Jolie Ringash, Eric Chen, Elena Elimova, Sara Hafezi-Bakhtiari, John Kim, Raymond Woo-Jun Jang, Di Maria Jiang, Geoffrey Liu, Patrik Rogalla, Gail Darling, Stephanie Moignard
Publikováno v:
Oncology. 99:49-56
Background: Trimodality therapy (TMT) with neoadjuvant chemoradiotherapy (nCRT) using concurrent carboplatin plus paclitaxel (CP) followed by surgery is the standard of care for locoregional esophageal or gastroesophageal junction (GEJ) cancers. Alte
Autor:
Junya Kitadani, Toshiyasu Ojima, Keiji Hayata, Hiroki Yamaue, Masaki Nakamura, Masahiro Katsuda, Mikihito Nakamori
Publikováno v:
Oncology. 99:57-61
Objectives: A regimen of S-1 combined with oxaliplatin (SOX) has been widely used as the first-line regimen for advanced gastric cancer. To further improve the antitumor efficacy for gastric cancer patients with peritoneal metastasis, we added nab-pa
Autor:
Masahiro Noda, Takaaki Arigami, Hiroshi Kurahara, Daisuke Matsushita, Satoshi Iino, Keishi Okubo, Yoshiaki Kita, Yoshikazu Uenosono, Yota Kawasaki, Shigehiro Yanagita, Sumiya Ishigami, Kosei Maemura, Shinichiro Mori, Ken Sasaki, Shoji Natsugoe
Publikováno v:
Oncology. 98:273-279
Objective: Chemotherapy is generally recommended as the first-line standard treatment in patients with liver metastasis from gastric cancer. However, the clinical impact of surgical treatment remains unclear in responders after chemotherapy. The pres
Autor:
Anna Maria Valentini, Rossella Donghia, Federica Di Pinto, Nicolo’ Schena, Raffaele Armentano, Graziana Arborea
Publikováno v:
Oncology. 98:566-574
To identify useful markers for prognostic and therapeutic purposes, The Cancer Genome Atlas (TCGA) provided a molecular classification of gastric cancers (GCs). Previous studies have used immunohistochemistry (IHC) and chromogenic in situ hybridizati
Autor:
Yoshikazu Uenosono, Daisuke Matsushita, Yoshiaki Kita, Shigehiro Yanagita, Shoji Natsugoe, Hiroshi Kurahara, Masahiro Noda, Ken Sasaki, Sumiya Ishigami, Keishi Okubo, Takaaki Arigami, Takao Ohtsuka, Shinichiro Mori
Publikováno v:
Oncology. 98:798-806
Objective: Although chemotherapy has been clinically recommended as the initial treatment for patients with peritoneal dissemination of gastric cancer, poor prognosis has been noted among the same patients. However, the prognostic significance of con
Autor:
Nozomi Ueno, Shinobu Tsuchida, Mitsuru Sasako, Tomoyuki Wakahara, Akihiro Toyokawa, Sadaki Asari, Kiyonori Kanemitsu
Publikováno v:
Oncology. 98:111-116
Introduction: Postoperative pancreas-related complications (PPRC) can cause critical conditions, including sepsis and intra-abdominal bleeding. Thus, it is important to identify patients who are at risk of clinically significant PPRC as early as poss
Autor:
Takamichi Komori, Masaaki Motoori, Kazumasa Fujitani, Susumu Miyazaki, Yasuhiro Miyazaki, Norihiro Matsuura, Hisateru Komatsu, Kazuhiro Iwase, Yujiro Nishizawa, Akira Tomokuni
Publikováno v:
Oncology. 98:29-34
Purpose: Neoadjuvant chemotherapy (NAC) followed by surgery is a promising treatment strategy for patients with advanced gastric cancer. Severe toxicity associated with the treatment may reduce the dose intensity of chemotherapy, resulting in the eff
Publikováno v:
Oncology. 100(3)
Background: Platinum + fluoropyrimidine is a standard front-line therapy for unresectable gastroesophageal adenocarcinoma (GA). Subsequent therapy recommendations are ramucirumab + paclitaxel (RAM/PAC), taxane, irinotecan, or trifluridine-tipiracil.
Autor:
Akihiko Sano, Yuki Shimoda, Hiroshi Saeki, Makoto Sakai, Keigo Hara, Makoto Sohda, Kengo Kuriyama, Nobuhiro Nakazawa, Munenori Ide, Ken Shirabe, Yasunari Ubukata, Tetsunari Oyama, Hiroomi Ogawa, Takehiko Yokobori
Publikováno v:
Oncology. 99(11)
Introduction: We investigated whether the expression of L-type amino acid transporter 1 (LAT-1) in clinical gastric cancer (GC) patients could predict patient therapeutic response to postoperative adjuvant chemotherapy. Methods: Immunohistochemistry